Ergomed shares fly on raised profit guidance, strong growth
Shares in specialist services provider to the pharmaceutical industry Ergomed (ERGO:AIM) jumped 11% to £11.80 on Tuesday after the company said 2021 profit would be ahead of analysts’ forecasts.
The company said ‘excellent’ trading across both Pharmacovigilance and Clinical Research Organisation businesses in the first half had continued through to the year ended in December, resulting ...